Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus

Mise à jour : Il y a 5 ans
Référence : NCT00003156

Femme Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of topotecan in treating patients with recurrent or refractory cancer of the uterus.


Critère d'inclusion

  • Sarcoma

Liens